ArticleJournal for immunotherapy of cancer2022

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.

Francois Bertucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.